In this position, Dr. Tsue (pronounced sue-A) provides the clinical oversight at The University of Kansas Cancer Center, ranked 44th nationally among hospital cancer programs by U.S. News & World Report.
“The clinical care program has a well-deserved reputation as one of the best,” said Dr. Tsue. “I think there are tremendous opportunities to enhance our record of success in our merger with Kansas City Cancer Center and our close collaboration with the booming cancer research activity on campus. We can build upon the quality of multidisciplinary care, which has become the hallmark on our patient-focused program.”
The
Physician-in-Chief position reports both to Roy Jensen, MD, director of
The University of Kansas Cancer Center, and Bob Page, president and
chief executive officer of The University of Kansas Hospital.“Terry Tsue has a track record of bringing different disciplines together to benefit patient care. He is both a caring physician and an outstanding researcher who will help both the clinical and research elements in the cancer center continue their spectacular record of quality and growth,” said Page.
Dr. Tsue is a graduate of Johns Hopkins University School of Medicine, and completed his residency at The University of Washington in Seattle, Washington.
He has served on the faculty of The University of Kansas School of Medicine since 1996, rising to become the Douglas A. Girod, MD, Endowed Professor of Head and Neck Surgical Oncology, and Vice Chairman, Department of Otolaryngology (Ear, Nose and Throat)-Head and Neck Surgery.
Dr. Tsue’s specific areas of interests include tumors of the mouth, throat, voice box, neck and thyroid glands.
This includes utilization of the latest techniques for preservation for tissues and function--including conservation laryngeal surgery and the endoscopic removal of head and neck cancers using laser and robotic techniques.
Dr. Tsue is nationally recognized for his expertise in reconstruction of head and neck defects including microvascular reconstruction of the jaw.
He also works closely with a multidisciplinary team to manage tumors of the skullbase--including the endoscopic removal of tumors and combined procedures involving neurosurgical approaches.
